Glenmark Pharma Fact Sheet, Glenmark Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Glenmark Pharma Fact Sheet    (GLPH)

Here is the latest financial fact sheet of Glenmark Pharma. For more details, see the Glenmark Pharma quarterly results and Glenmark Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

GLENMARK PHARMA Price History

Price Rs 288.6
Mkt Cap Rs m 81,434
Vol '000 50.7
P/E X 10.2
P/CF X 6.5
EPS (TTM) Rs 28.4
% ch % 1.0
No. of shares m 282.17
% ch week % -0.4
% ch 1-mth % -22.1
% ch 12-mth % -51.9
52 week H/L Rs 706.9/269.8
(As on Oct 17, 2019 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

GLENMARK PHARMA Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
GLENMARK PHARMA EQUITY SHARE DATA
High Rs8791,262993930712 
Low Rs752672729517484 
Sales per share (Unadj.) Rs244.4271.1325.5322.6349.6 
Earnings per share (Unadj.) Rs17.526.339.328.532.8 
Diluted earnings per shareRs16.826.339.328.532.8 
Cash flow per share (Unadj.) Rs27.134.648.739.244.3 
Dividends per share (Unadj.) Rs2.002.002.002.002.00 
Adj. dividends per shareRs1.922.002.002.002.00 
Dividend yield (eoy) %0.20.20.20.30.3 
Book value per share (Unadj.) Rs86.1128.6159.2183.0198.6 
Adj. book value per shareRs82.8128.6159.2183.0198.6 
Shares outstanding (eoy) m271.29282.16282.17282.17282.17 
Bonus/Rights/Conversions  --ESOP-- 
Price / Sales ratio x3.33.62.62.21.7 
Avg P/E ratio x46.636.721.925.418.2 
P/CF ratio (eoy) x30.127.917.718.513.5 
Price / Book Value ratio x9.57.55.44.03.0 
Dividend payout %11.47.65.17.06.1 
Avg Mkt Cap Rs m221,284272,778242,991204,206168,625 
No. of employees `0009.510.013.013.712.0 
Total wages/salary Rs m12,02413,78216,40818,71820,561 
Avg. sales/employee Rs Th6,961.17,630.57,083.96,636.88,196.0 
Avg. wages/employee Rs Th1,262.51,374.81,265.41,364.71,708.1 
Avg. net profit/employee Rs Th499.0741.2855.1586.1768.5 
GLENMARK PHARMA INCOME DATA
Net Sales Rs m66,29876,49691,85791,03198,655 
Other income Rs m2192003749142,081 
Total revenues Rs m66,51676,69692,23091,945100,736 
Gross profit Rs m10,22514,37220,36716,15415,858 
Depreciation Rs m2,6002,3432,6443,0193,259 
Interest Rs m1,9021,7892,3732,8563,346 
Profit before tax Rs m5,94310,44015,72411,19311,335 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00-81001,672 
Tax Rs m1,1903,0093,8273,1553,756 
Profit after tax Rs m4,7527,43011,0888,0399,250 
Gross profit margin %15.418.822.217.716.1 
Effective tax rate %20.028.824.328.233.1 
Net profit margin %7.29.712.18.89.4 
GLENMARK PHARMA BALANCE SHEET DATA
Current assets Rs m53,19959,04368,74669,88766,968 
Current liabilities Rs m37,11139,99327,02732,87940,211 
Net working cap to sales %24.324.945.440.727.1 
Current ratio x1.41.52.52.11.7 
Inventory Days Days7075858183 
Debtors Days Days138119969381 
Net fixed assets Rs m17,44521,41624,13228,89233,322 
Share capital Rs m271282282282282 
"Free" reserves Rs m23,08636,01444,64351,35355,770 
Net worth Rs m23,35736,29644,92551,63556,052 
Long term debt Rs m25,74424,87345,36341,41835,738 
Total assets Rs m87,429101,929117,639125,954132,888 
Interest coverage x4.16.87.64.94.4 
Debt to equity ratio x1.10.71.00.80.6 
Sales to assets ratio x0.80.80.80.70.7 
Return on assets %7.69.011.48.69.5 
Return on equity %20.320.524.715.616.5 
Return on capital %16.020.019.115.117.8 
Exports to sales %44.843.2000 
Imports to sales %7.17.4000 
Exports (fob) Rs m29,72033,044000 
Imports (cif) Rs m4,6805,672000 
Fx inflow Rs m31,29936,94556,15236,31762,998 
Fx outflow Rs m10,85661,0668,0849,72022,859 
Net fx Rs m20,443-24,12248,06826,59840,140 
GLENMARK PHARMA CASH FLOW
From Operations Rs m 4,817 3,449 6,574 16,481 13,242 
From Investments Rs m -5,400 -8,802 -7,124 -10,133 -6,990 
From Financial Activity Rs m 1,992 6,986 5,432 -4,685 -7,387 
Net Cashflow Rs m -311 934 1,992 1,770 -2,971 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 48.3%
Foreign collaborators 0.0%
Indian inst/Mut Fund 6.9%
FIIs 34.4%
ADR/GDR 0.0%
Free float 10.5%
Shareholders 56,727
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai - 400 026
E-MAIL complianceofficer@glenmarkpharma.com WEB www.glenmarkpharma.com
TELEPHONE (022) 4018 9999 FAX (022) 4018 9986
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computer, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR Walker, Chandiok & Co.
CHM: Glenn Saldanha (MD) COMP SEC: Sanjay Kumar Chowdhary YEAR OF INC: 1977 BSE CODE: 532296 FV (Rs): 1 DIV YIELD (%): 0.7

Read: GLENMARK PHARMA 2018-19 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   PFIZER  NATCO PHARMA  ELDER PHARMA  SANOFI INDIA  LUPIN  

Compare GLENMARK PHARMA With:   PFIZER  NATCO PHARMA  ELDER PHARMA  SANOFI INDIA  LUPIN  

Compare GLENMARK PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Bank Credit Growth, World Bank on Developments in India, and Top Cues in Focus Today(Pre-Open)

On Thursday, Indian share markets rose sharply during closing hours and ended on a strong note, extending gains to the fifth day.

Views on news

GLENMARK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of GLENMARK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

GLENMARK PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 53.1% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, GLENMARK PHARMA has posted a net profit of Rs 1 bn (down 53.1% YoY). Sales on the other hand came in at Rs 23 bn (up 7.3% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 6.6% (Quarterly Result Update)

Jun 3, 2019 | Updated on Jun 3, 2019

For the quarter ended March 2019, GLENMARK PHARMA has posted a net profit of Rs 2 bn (up 6.6% YoY). Sales on the other hand came in at Rs 26 bn (up 12.4% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of GLENMARK PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA - GSK PHARMA COMPARISON

COMPARE GLENMARK PHARMA WITH

MARKET STATS